Policy / Pricing FDA floats new clinical trial reforms; Takeda punts Denali brain drug BioPharma DiveIn its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms.Policy / PricingRead full story pharminent April 6, 2026 (Last updated: April 6, 2026) BioPharma Dive In its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms. Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Neurocrine to acquire Prader-Will drug in $2.9B Soleno buyoutNext: Amgen scores with new thyroid eye disease formulation Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
